10x Genomics, Inc.
TXG
$26.14
-$1.11-4.07%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -59.95M | -48.95M | -92.99M | -62.41M | -50.75M |
| Total Depreciation and Amortization | 11.49M | 11.71M | 11.42M | 11.88M | 8.62M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 39.03M | 45.94M | 40.09M | 48.94M | 43.97M |
| Change in Net Operating Assets | -6.30M | 17.07M | 16.17M | -9.93M | -5.96M |
| Cash from Operations | -15.73M | 25.76M | -25.30M | -11.53M | -4.13M |
| Capital Expenditure | -2.91M | -3.45M | -15.24M | -25.36M | -4.56M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.54M | 16.55M | 20.14M | 20.89M | 124.52M |
| Cash from Investing | 10.63M | 13.10M | 4.90M | -4.46M | 119.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -5.81M |
| Issuance of Common Stock | 1.64M | 5.61M | 4.37M | 7.10M | 2.40M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.64M | 5.61M | 4.37M | 7.10M | -3.41M |
| Foreign Exchange rate Adjustments | -48.00K | 77.00K | -85.00K | -49.00K | 24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.50M | 44.55M | -16.12M | -8.94M | 112.44M |
